SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Account Payables

Amounts the company owes suppliers for goods and services received.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Account Payables · Q1 FY2026 · quarter ended Mar 2026

Account payables of $3.51M in Q1 FY2026

Q1 FY2026 account payables was $3.51M.

Context

  • Account payables amounted to 1.4% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.51M+30.3% QoQ
Last fiscal yearDec 2025
$2.7M— YoY
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Account Payables history

USD · from the balance sheet

Latest · FY2025
2.7M USD
Year-over-year change
—

Account Payables vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
  • Account payables amounts to 1.4% of total assets for SGP, versus a peer median of 2.1%.
SGP Competitors
Account Payables for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$971M USD+8.6%+2.5%3.1%
BLCOBausch + Lomb CorporationJun 2026$426M USD-5.1%+7.0%3.1%
GKOSGlaukos CorporationJun 2026$19.14M USD+39.9%+19.6%2.1%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$18.81M USD+14.6%+21.0%6.5%
STAASTAAR Surgical CompanyApr 2026$8.7M USD-24.2%-0.0%1.9%
OCULOcular Therapeutix, Inc.Mar 2026$8.03M USD+73.5%-6.8%1.1%
RXSTRxSight, Inc.Mar 2026$7.12M USD+0.2%+26.8%2.3%
OCSOculis Holding AGMar 2026CHF 4.48M CHF+3.0%-22.5%1.8%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$3.51M USD——1.4%
SGHTSight Sciences, Inc.Mar 2026$1.49M USD-46.3%-20.6%1.4%
Peer median (excluding SGP) —+3.0%+2.5%2.1%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.